Physician profile
John Anthony Martini
NPI 1033119276
$2,226.05
in general payments reported to CMS, 2019-2025
14 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $112 · 2021: $186 · 2022: $891 · 2023: $224 · 2024: $285 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $606.17 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $349.14 | 2022-2023 | Farxiga, Brilinta, Breztri |
| Recor Medical INC | $157.14 | 2024 | Paradise Renal Denervation System |
| Stryker Corporation | $143.94 | 2022 | |
| Novo Nordisk INC | $139.05 | 2022 | |
| Alexion Pharmaceuticals, INC. | $128.15 | 2024 | |
| Pfizer INC. | $127.03 | 2019-2022 | |
| Glaxosmithkline, LLC. | $125.31 | 2025 | |
| Organogenesis INC. | $124.87 | 2019 | |
| Genzyme Corporation | $119.46 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $96.22 | 2020 | |
| Portola Pharmaceuticals, LLC | $57.70 | 2019 | |
| Merck Sharp & Dohme LLC | $29.93 | 2019-2021 | |
| Bsn Medical INC | $21.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.